Title | Type | ![]() |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | %Female (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer![]() | journal | 1.929 Q1 | 117 | 83 | 63 | 2067 | 318 | 60 | 5.05 | 24.90 | 36.31 | ![]() |
2 | Frontiers in Pharmacology![]() | journal | 1.886 Q1 | 154 | 303 | 628 | 22107 | 2862 | 592 | 4.48 | 72.96 | 41.01 | ![]() |
3 | Expert Review of Vaccines![]() | journal | 1.772 Q1 | 105 | 107 | 459 | 9145 | 1608 | 408 | 3.46 | 85.47 | 41.14 | ![]() |
4 | International Journal of Neuropsychopharmacology![]() | journal | 1.764 Q1 | 125 | 177 | 548 | 9768 | 2285 | 533 | 4.05 | 55.19 | 41.40 | ![]() |
5 | International Journal for Parasitology: Drugs and Drug Resistance![]() | journal | 1.688 Q1 | 47 | 27 | 91 | 1288 | 394 | 91 | 4.25 | 47.70 | 35.66 | ![]() |
6 | CNS Neuroscience and Therapeutics![]() | journal | 1.553 Q1 | 91 | 125 | 464 | 6311 | 1557 | 348 | 3.27 | 50.49 | 40.61 | ![]() |
7 | Diabetes, Metabolic Syndrome and Obesity![]() | journal | 1.463 Q1 | 64 | 57 | 153 | 2744 | 697 | 149 | 4.77 | 48.14 | 41.47 | ![]() |
8 | Altex![]() | journal | 1.320 Q1 | 64 | 36 | 127 | 1912 | 477 | 103 | 3.80 | 53.11 | 46.86 | ![]() |
9 | Cancer Biology and Therapy![]() | journal | 1.313 Q1 | 130 | 208 | 520 | 8550 | 1641 | 488 | 2.95 | 41.11 | 37.32 | ![]() |
10 | Perspectives in Medicinal Chemistry![]() | journal | 1.285 Q1 | 17 | 3 | 5 | 193 | 29 | 5 | 5.80 | 64.33 | 37.50 | ![]() |
11 | Cancer Chemotherapy and Pharmacology![]() | journal | 1.266 Q1 | 122 | 280 | 889 | 8763 | 2864 | 877 | 3.26 | 31.30 | 31.30 | ![]() |
12 | Infection and Drug Resistance![]() | journal | 1.263 Q1 | 65 | 39 | 82 | 2276 | 321 | 82 | 4.32 | 58.36 | 37.31 | ![]() |
13 | Cardiovascular Therapeutics![]() | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | 29.02 | ![]() |
14 | Pharmacogenomics and Personalized Medicine![]() | journal | 1.195 Q1 | 37 | 15 | 63 | 858 | 275 | 63 | 4.46 | 57.20 | 37.04 | ![]() |
15 | PharmacoEconomics![]() | journal | 1.143 Q1 | 118 | 105 | 294 | 5466 | 733 | 245 | 2.44 | 52.06 | 42.48 | ![]() |
16 | Therapeutic Advances in Neurological Disorders![]() | journal | 1.113 Q2 | 68 | 30 | 84 | 1534 | 329 | 81 | 3.50 | 51.13 | 40.86 | ![]() |
17 | Journal of Cardiovascular Pharmacology and Therapeutics![]() | journal | 1.110 Q2 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | 30.39 | ![]() |
18 | Journal of Enzyme Inhibition and Medicinal Chemistry![]() | journal | 1.095 Q2 | 92 | 139 | 403 | 5786 | 1330 | 402 | 3.29 | 41.63 | 41.20 | ![]() |
19 | Core Evidence (discontinued)![]() | journal | 1.051 Q2 | 29 | 8 | 32 | 471 | 130 | 31 | 4.30 | 58.88 | 33.33 | ![]() |
20 | Drug Design, Development and Therapy![]() | journal | 0.982 Q2 | 94 | 527 | 424 | 23818 | 1498 | 422 | 3.44 | 45.20 | 38.31 | ![]() |
21 | Human Vaccines and Immunotherapeutics![]() | journal | 0.973 Q2 | 93 | 381 | 1253 | 16584 | 2510 | 975 | 1.93 | 43.53 | 46.24 | ![]() |
22 | Journal of Pharmacological Sciences![]() | journal | 0.948 Q2 | 101 | 136 | 428 | 4858 | 1068 | 427 | 2.46 | 35.72 | 29.17 | ![]() |
23 | Journal of Physiology and Pharmacology![]() | journal | 0.936 Q2 | 89 | 90 | 263 | 5070 | 769 | 263 | 3.05 | 56.33 | 47.20 | ![]() |
24 | Vaccines![]() | journal | 0.882 Q2 | 85 | 51 | 44 | 4651 | 82 | 42 | 1.86 | 91.20 | 49.44 | ![]() |
25 | Pharmacological Reports![]() | journal | 0.864 Q2 | 98 | 183 | 499 | 8844 | 1348 | 497 | 2.53 | 48.33 | 50.42 | ![]() |
26 | BMC pharmacology & toxicology![]() | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | 35.20 | ![]() |
27 | Biomedicine and Pharmacotherapy![]() | journal | 0.810 Q2 | 149 | 289 | 375 | 10282 | 982 | 372 | 2.64 | 35.58 | 39.93 | ![]() |
28 | Drug Metabolism and Pharmacokinetics![]() | journal | 0.805 Q2 | 75 | 65 | 237 | 2463 | 584 | 218 | 1.89 | 37.89 | 32.42 | ![]() |
29 | Biomarker Insights![]() | journal | 0.800 Q2 | 40 | 68 | 45 | 5487 | 111 | 44 | 1.83 | 80.69 | 37.33 | ![]() |
30 | Journal of Pharmacy and Pharmaceutical Sciences![]() | journal | 0.719 Q2 | 88 | 62 | 140 | 3237 | 389 | 140 | 2.69 | 52.21 | 37.86 | ![]() |
31 | Chinese Medicine![]() | journal | 0.706 Q2 | 56 | 38 | 78 | 1753 | 173 | 75 | 2.06 | 46.13 | 39.24 | ![]() |
32 | Drugs in Context![]() | journal | 0.681 Q2 | 36 | 20 | 23 | 761 | 43 | 21 | 1.65 | 38.05 | 56.16 | ![]() |
33 | Korean Journal of Physiology and Pharmacology![]() | journal | 0.642 Q2 | 40 | 72 | 215 | 2722 | 370 | 215 | 1.78 | 37.81 | 37.34 | ![]() |
34 | Antiviral Chemistry and Chemotherapy![]() | journal | 0.621 Q2 | 59 | 20 | 42 | 577 | 91 | 41 | 1.95 | 28.85 | 33.33 | ![]() |
35 | International Journal of Immunopathology and Pharmacology![]() | journal | 0.579 Q3 | 65 | 71 | 373 | 2332 | 612 | 365 | 1.51 | 32.85 | 46.56 | ![]() |
36 | Saudi Pharmaceutical Journal![]() | journal | 0.563 Q3 | 76 | 97 | 180 | 3091 | 449 | 175 | 2.61 | 31.87 | 38.44 | ![]() |
37 | Current Therapeutic Research![]() | journal | 0.557 Q3 | 46 | 21 | 91 | 530 | 160 | 86 | 1.95 | 25.24 | 25.45 | ![]() |
38 | Interdisciplinary Toxicology![]() | journal | 0.550 Q3 | 38 | 29 | 99 | 1144 | 204 | 98 | 1.49 | 39.45 | 29.63 | ![]() |
39 | DARU, Journal of Pharmaceutical Sciences![]() | journal | 0.543 Q3 | 58 | 55 | 256 | 2136 | 518 | 230 | 1.99 | 38.84 | 34.92 | ![]() |
40 | Drug, Healthcare and Patient Safety![]() | journal | 0.531 Q3 | 30 | 17 | 66 | 635 | 123 | 60 | 1.76 | 37.35 | 32.08 | ![]() |
41 | Pharmaceutical Biology![]() | journal | 0.513 Q3 | 88 | 240 | 622 | 9910 | 1099 | 622 | 1.81 | 41.29 | 39.82 | ![]() |
42 | Drugs in R and D![]() | journal | 0.479 Q3 | 54 | 35 | 97 | 1269 | 171 | 96 | 1.58 | 36.26 | 35.00 | ![]() |
43 | Records of Natural Products![]() | journal | 0.404 Q3 | 41 | 111 | 175 | 2819 | 223 | 174 | 1.06 | 25.40 | 41.18 | ![]() |
44 | Acta Poloniae Pharmaceutica![]() | journal | 0.359 Q3 | 52 | 145 | 431 | 4390 | 478 | 429 | 0.95 | 30.28 | 47.02 | ![]() |
45 | Revista Espanola de Quimioterapia![]() | journal | 0.327 Q3 | 32 | 78 | 160 | 1293 | 136 | 121 | 0.85 | 16.58 | 44.89 | ![]() |
46 | Natural Product Communications![]() | journal | 0.324 Q3 | 63 | 539 | 1355 | 13358 | 1472 | 1333 | 1.01 | 24.78 | 40.73 | ![]() |
47 | Journal of Experimental Pharmacology![]() | journal | 0.323 Q3 | 23 | 4 | 4 | 322 | 9 | 4 | 3.00 | 80.50 | 35.29 | ![]() |
48 | EXCLI Journal![]() | journal | 0.302 Q3 | 55 | 121 | 285 | 5643 | 378 | 245 | 1.48 | 46.64 | 38.85 | ![]() |
49 | Journal of Receptor, Ligand and Channel Research![]() | journal | 0.223 Q3 | 13 | 5 | 13 | 470 | 11 | 13 | 0.64 | 94.00 | 38.46 | ![]() |
50 | Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas![]() | journal | 0.196 Q3 | 26 | 42 | 176 | 2295 | 88 | 170 | 0.46 | 54.64 | 40.76 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®